Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parecoxib after pancreaticoduodenectomy under an ERAS program
ChiCTR2000032535Phase 4Recruiting
- Sponsor
- Peking University First Hospital
- Start
- Jun 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of parecoxib in postoperative pain (2 arms), sponsored by Peking University First Hospital. Primary endpoints: Pain score and Opioid drug use. Started Jun 2017; status: recruiting.
02
Drugs
parecoxib
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2000032535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032535.